RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Suda Pharmaceuticals EBIT 2024

Suda Pharmaceuticals EBIT

0 AUD

Suda Pharmaceuticals Dividend yield

Ticker

SUD.AX

ISIN

AU000000SUD7

WKN

A1J9SF

In 2024, Suda Pharmaceuticals's EBIT was 0 AUD, a 0% increase from the 0 AUD EBIT recorded in the previous year.

The Suda Pharmaceuticals EBIT history

YEAREBIT (undefined AUD)
2024e-
2023e-
2022e-
2021-4,659.57
2020-4,751.92
2019-2,324.91
2018-2,491.63
2017-1,566.89
2016-2,917.72
2015-3,977.84
2014-1,890
2013-1,780
2012-1,950
2011-2,580
2010-2,220
2009-2,940
2008-3,080
2007-1,480
2006280
2005-1,680
2004-500
2003-1,040
2002-750

Suda Pharmaceuticals Aktienanalyse

What does Suda Pharmaceuticals do?

Suda Pharmaceuticals Ltd is an Australian pharmaceutical company specializing in the development and marketing of drugs. The company was founded in 2000 and is headquartered in Perth, Western Australia. It is listed on the Australian Stock Exchange and has offices in the UK and the USA. Suda Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Suda Pharmaceuticals's EBIT

Suda Pharmaceuticals's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Suda Pharmaceuticals's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Suda Pharmaceuticals's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Suda Pharmaceuticals’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Suda Pharmaceuticals Stock

How much did Suda Pharmaceuticals achieve in EBIT for the current year?

In the current year, Suda Pharmaceuticals has achieved an EBIT of 0 AUD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Suda Pharmaceuticals.

How has the EBIT of Suda Pharmaceuticals developed in recent years?

The EBIT of Suda Pharmaceuticals has increased by 0% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Suda Pharmaceuticals?

The EBIT of Suda Pharmaceuticals is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Suda Pharmaceuticals pay?

Over the past 12 months, Suda Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Suda Pharmaceuticals is expected to pay a dividend of 0 AUD.

What is the dividend yield of Suda Pharmaceuticals?

The current dividend yield of Suda Pharmaceuticals is .

When does Suda Pharmaceuticals pay dividends?

Suda Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Suda Pharmaceuticals?

Suda Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Suda Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Suda Pharmaceuticals located?

Suda Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Suda Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Suda Pharmaceuticals from 5/31/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.

When did Suda Pharmaceuticals pay the last dividend?

The last dividend was paid out on 5/31/2024.

What was the dividend of Suda Pharmaceuticals in the year 2023?

In the year 2023, Suda Pharmaceuticals distributed 0 AUD as dividends.

In which currency does Suda Pharmaceuticals pay out the dividend?

The dividends of Suda Pharmaceuticals are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Suda Pharmaceuticals

Our stock analysis for Suda Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Suda Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.